Kimberly Gentile
Chief Tech/Sci/R&D Officer at BIOHAVEN LTD.
Net worth: 4 M $ as of 2024-04-29
Kimberly Gentile active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | - | - |
Portage Pharmaceutical Ltd.
 Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Chief Operating Officer | - | - |
Career history of Kimberly Gentile
Former positions of Kimberly Gentile
| Companies | Position | Start | End |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | - | 2022-10-02 |
| Corporate Officer/Principal | 2014-01-31 | 2022-10-02 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 1999-12-31 | 2014-01-31 |
| SCIREX Corp. | Corporate Officer/Principal | 1995-12-31 | 2000-05-31 |
Training of Kimberly Gentile
| Salem State University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 2 |
| 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
| SCIREX Corp. | Commercial Services |
Portage Pharmaceutical Ltd.
Portage Pharmaceutical Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Juvenescence Ltd., Portage Pharmaceutical Ltd. is a research and developer of biotechnology pharmaceutical drugs. The company is based in Toronto, Canada. Portage Pharmaceutical was acquired by Juvenescence Ltd. from Portage Biotech, Inc. on March 04, 2021 for $193.25 million. The CEO of the Canadian company is Frank W. Marcoux. | Commercial Services |
| Biohaven Ltd. |
- Stock Market
- Insiders
- Kimberly Gentile
- Experience
